0001872608-21-000001.txt : 20210714 0001872608-21-000001.hdr.sgml : 20210714 20210714163101 ACCESSION NUMBER: 0001872608-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210714 DATE AS OF CHANGE: 20210714 EFFECTIVENESS DATE: 20210714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allevion Therapeutics, Inc. CENTRAL INDEX KEY: 0001872608 IRS NUMBER: 852286607 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-406273 FILM NUMBER: 211090507 BUSINESS ADDRESS: STREET 1: 14252 CULVER DRIVE STREET 2: SUITE A-333 CITY: IRVINE STATE: CA ZIP: 92604 BUSINESS PHONE: (949) 701-3545 MAIL ADDRESS: STREET 1: 14252 CULVER DRIVE STREET 2: SUITE A-333 CITY: IRVINE STATE: CA ZIP: 92604 D 1 primary_doc.xml X0708 D LIVE 0001872608 Allevion Therapeutics, Inc. 14252 CULVER DRIVE SUITE A-333 IRVINE CA CALIFORNIA 92604 (949) 701-3545 DELAWARE None None Corporation true 2018 Shahram Moaddeb 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Executive Officer Director Promoter Mr. Moaddeb is the founder, chairman of the board and chief executive officer of the company. Jack Wang 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Director Mr. Wang serves as a director of the company. Roy Tanaka 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Director Mr. Tanaka serves as a director of the company. Dan Dearen 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Director Mr. Dearen serves a director of the company. Mahmood Razavi 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Director Mr. Razavi serves as a diector of the company. Randy Werneth 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Director Mr. Werneth serves as a director of the company. Pintoo Shah 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Executive Officer Mr. Shah serves as an executive officer of the company. Neal Hermanowicz 14252 Culver Drive, Suite A-333 Irvine CA CALIFORNIA 92604 Executive Officer Mr. Hermanowicz serves as a executive officer of the company. Biotechnology Decline to Disclose 06b false 2021-06-29 false true false 1000000 1000000 1000000 0 false 1 0 0 200000 true Up to approximately $200,000 of the proceeds of the offering may be used to reimburse officers for out-of-pocket expenses incurred in connection with the offering and to pay officer salaries. false Allevion Therapeutics, Inc. Shahram Moaddeb Shahram Moaddeb Chief Executive Officer 2021-07-14